Addiction | Financial Buzz

Breaking News Cannabis Buzz Domestic International Market News Medical Use Pharmaceutical The Market Buzz

Breaking News: Mindleap Health™ Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

financial buzz08/04/2020

5928

Mydecine Innovations Group™ (CSE: MYCO) (OTC: MYCOF), is pleased to announce that its subsidiary, Mindleap Health™ (“Mindleap” or the “Company”) based in Vancouver, British Columbia, is expanding it’s digital...

Breaking News Healthcare Investing News Market News

Breaking News: Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

financial buzz07/14/202007/14/2020

2932

Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO), is pleased to announce that, further to its press release on June 10, 2020, it has entered into a definitive share...

Breaking News Cannabis Buzz Healthcare Market News The Market Buzz

Breaking News: Numinus Announces 2020 Operational Plans to Scale

financial buzz05/28/2020

5882

Numinus Wellness Inc. (“Numinus”), recently listed on the TSX Venture Exchange (TSX-V: NUMI), is pleased to report its near-term goals to advance our mission to address the universal desire...

Behind the Buzz Breaking News Corporate Overview Healthcare Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Behind the Buzz” Show: Numinus Wellness (TSX-V: NUMI) Corporate Overview

financial buzz05/26/202005/27/2020

6439

FinancialBuzz.com’s latest Behind the Buzz Show: Featuring Our Corporate Overview on Numinus Wellness Inc. Chairman & CEO Payton Nyquvest Former Director, VP and Head of Sales at Mackie Research...

Breaking News Financial Buzz Reports Healthcare Market News Technology The Market Buzz

The Buzz Surrounding: Numinus Wellness Inc. (TSX-V: NUMI)

financial buzz05/26/202006/15/2020

24592

Domestic Politics

FDA Takes Action against 17 Companies Illegally Selling Products to Treat Alzheimer’s Disease

Zehong (Marco) Zhou02/11/2019

5627

2

The U.S. Food and Drug Administration posted on Monday, 12 warning letters and five online advisory letters issued to both foreign and domestic companies that are illegally selling more...

Biotechnology Investing News Pharmaceutical

Emergent BioSolutions to Buy Adapt Pharma

Austin Chiu08/29/201808/29/2018

5874

2

Emergent BioSolutions (NYSE: EBS) announced on Tuesday it would buy privately held Adapt Pharma, strengthening its portfolio with Narcan, the only FDA approved needle-free emergency opioid overdose treatment. Addiction...

Tag: Addiction